about
Structure of human type II 5 alpha-reductase geneAbsence of ligand-induced regulation of kinin receptor expression in the rabbitProteomic dataset for altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cellsSystems biology combining human- and animal-data miRNA and mRNA data identifies new targets in ureteropelvic junction obstructionGlobal gene expression analysis of early response to chemotherapy treatment in ovarian cancer spheroidsImmunohistochemical profiling of benign, low malignant potential and low grade serous epithelial ovarian tumors.Role of malignant ascites on human mesothelial cells and their gene expression profilesGenome-wide analysis of gestational gene-environment interactions in the developing kidneyIn vivo DNase I-mediated footprinting analysis along the human bradykinin B1 receptor (BDKRB1) gene promoter: evidence for cell-specific regulationA new paradigm for transcription factor TFIIB functionalityThe mannose receptor LY75 (DEC205/CD205) modulates cellular phenotype and metastatic potential of ovarian cancer cells.Novel combination of sorafenib and celecoxib provides synergistic anti-proliferative and pro-apoptotic effects in human liver cancer cells.Histone deacetylase 1 and 2 regulate Wnt and p53 pathways in the ureteric bud epitheliumHistone deacetylase (HDAC) activity is critical for embryonic kidney gene expression, growth, and differentiation.Regulation of kinin-induced contraction and DNA synthesis by inflammatory cytokines in the smooth muscle of the rabbit aorta.BCAT1 expression associates with ovarian cancer progression: possible implications in altered disease metabolism.The RUNX1 transcription factor is expressed in serous epithelial ovarian carcinoma and contributes to cell proliferation, migration and invasion.Inhibition of RUNX2 transcriptional activity blocks the proliferation, migration and invasion of epithelial ovarian carcinoma cells.Genome-wide analysis of the p53 gene regulatory network in the developing mouse kidneyRole of the polypeptide N-acetylgalactosaminyltransferase 3 in ovarian cancer progression: possible implications in abnormal mucin O-glycosylation.Suppression of the grainyhead transcription factor 2 gene (GRHL2) inhibits the proliferation, migration, invasion and mediates cell cycle arrest of ovarian cancer cells.The strand separation and nuclease activities associated with YB-1 are dispensable for cisplatin resistance but overexpression of YB-1 in MCF7 and MDA-MB-231 breast tumor cells generates several chemoresistance signatures.Akt confers cisplatin chemoresistance in human gynecological carcinoma cells by modulating PPM1D stability.Molecular mechanisms of sorafenib action in liver cancer cells.Characterization of DOK1, a candidate tumor suppressor gene, in epithelial ovarian cancer.COX-2-dependent and COX-2-independent mode of action of celecoxib in human liver cancer cells.A metabolic labeling approach for glycoproteomic analysis reveals altered glycoprotein expression upon GALNT3 knockdown in ovarian cancer cellsCharacterization of a fluorescent conjugate of the rabbit angiotensin AT(1) receptor.Antagonist-induced intracellular sequestration of rabbit bradykinin B(2) receptor.Cloning and preliminary pharmacological characterization of the anaphylatoxin C5a receptor in the rabbit.Non-competitive pharmacological antagonism at the rabbit B(1) receptor.Heterogeneity in the Xenopus ribosomal transcription factor xUBF has a molecular basis distinct from that in mammals.Ligand-mediated regulation of kinin receptors in the rabbit.Bradykinin B2 receptor gene polymorphism is associated with altered urinary albumin/creatinine values in diabetic patients.YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation).Agonist-induced translocation of the kinin B(1) receptor to caveolae-related rafts.Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans.Specimen quality evaluation in Canadian biobanks participating in the COEUR repository.Hic-5 regulates epithelial to mesenchymal transition in ovarian cancer cells in a TGFβ1-independent manner.Altered expression of different GalNAc‑transferases is associated with disease progression and poor prognosis in women with high-grade serous ovarian cancer.
P50
Q28253733-92119005-9A6A-4CEA-B276-95279C1CBBF0Q28345492-747B4043-E0DC-4D26-BB2F-0C24830412A5Q28830290-744FDBC8-3250-47E4-AF81-D487DD90EC86Q30253062-8AA33672-44AA-4210-BE0A-4495FADA3E6AQ33321330-124F8C50-3229-4B1B-B331-2D88738F0CE0Q33387074-637E7900-63F1-4348-A58C-FDC61008C91FQ33559857-50E9A83D-75E5-42F2-98D3-AD683E028B70Q34131714-7A3613AD-86C1-47D7-AACB-DB4FAC4D4D1AQ34393048-276799C7-6FCB-408F-81AC-6C16738D008AQ34398871-887F2308-3DB0-4CAE-89B2-EED6ACC5E241Q34513833-C8860EF7-AB7C-4CEB-9503-EBCC9E5311C6Q34775779-FD4698FB-8D88-4C06-BA8A-F0A18BE27C00Q35178908-0C4CB918-E8BD-47C0-889F-7A0E24EF9CD1Q35213401-3AA7643E-B2F8-44F2-A45F-134FD405A34DQ35872768-2FA8C22C-10F7-4F4C-89BC-16D354FBE7DCQ36544617-B0A65B28-D1E2-4FC2-9E11-C01300179C70Q36798094-AB42ED4E-864C-4177-AECD-726F6CD847E5Q37215827-5F61736E-E8A2-4307-A07B-8E98C072EE72Q37234873-BE50BA53-FE88-46A0-BE3B-DCB2FE839D4BQ37660331-2CDD9582-B7F9-4498-8B68-D33E773E4DF1Q38288773-CF1D5167-1A99-4213-A208-FDEFF0948DC3Q38289855-95E675EF-90E4-40F7-999C-C9598441B7FAQ38963051-7CF67AF0-B397-437B-B85D-7D04AF5B7F91Q39313526-F320FE0C-A1CF-48D6-850F-EEF24FD2F258Q39487546-52436644-6EAD-4F64-8CDF-F7FF323A37ABQ39575398-8CFE0582-84AF-43B5-993E-563E7D4CE435Q39837844-386C0495-C2A0-4E11-B6C0-2EE966043C64Q40651399-6DA29691-F1A6-4A31-B148-35F35C65CF18Q40873534-A1064D6E-2627-406D-B917-785619C498DFQ42148720-C64D6180-CA14-4087-8EF8-314A55890CF3Q42249590-AD4793EE-AF4F-4BA9-96B2-D29A2E17D897Q42622975-D4DA131E-97F8-4B47-B022-921C4E4CD8BAQ43547447-E0AC43AA-A1E1-4EFF-B7C8-FAF27D0006DBQ44003398-F97EE073-EE9B-48C9-9906-B1144D56AE31Q44317031-A9B5232B-FC07-4FAE-A278-BD9875D4C504Q45712928-806C934A-F07E-4E41-9031-337D4FC10529Q46477408-DFF58872-8807-414C-8D76-852DDE49A851Q46484472-EBA52DB4-46EB-44A1-8A9D-EB0F45D0FC33Q47107385-8C17CEC5-7230-480F-AC9E-2E6784D6BBD4Q47640704-B16410F8-5E42-45CD-B716-AA0B1E73A589
P50
description
Forscher
@de
chercheur et professeur d'université
@fr
investigador
@es
researcher and university professor
@en
ricercatore
@it
wetenschapper
@nl
研究者
@zh
name
D Bachvarov
@ast
D Bachvarov
@es
D Bachvarov
@nl
Dimcho Bachvarov
@en
Dimcho Bachvarov
@fr
type
label
D Bachvarov
@ast
D Bachvarov
@es
D Bachvarov
@nl
Dimcho Bachvarov
@en
Dimcho Bachvarov
@fr
altLabel
D Bachvarov
@en
D Bachvarov
@fr
prefLabel
D Bachvarov
@ast
D Bachvarov
@es
D Bachvarov
@nl
Dimcho Bachvarov
@en
Dimcho Bachvarov
@fr
P108
P1153
7003345405
P2038
Dimcho_Bachvarov2
P21
P31
P496
0000-0001-6509-9599